Clinical Trial Update: Safety and Efficacy of Doxorubicin-eluting-bead Embolization in Patients With Advanced Hepatocellular Carcinoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing safety and efficacy of doxorubicin-eluting beads embolization in patients with advanced hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• doxorubicin-eluting bead embolization (doxorubicin-eluting bead embolization)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hepatocellular Carcinoma | Phase 4 | Status: UNKNOWN